Since 1986 when we first opened, Boston IVF has conducted ground-breaking research that has contributed to vast improvements in assisted reproductive technologies and fertility treatment. Patients at Boston IVF benefit from working with the experts who conducted these studies; when appropriate, patients are invited to participate in research studies as well. Below are brief descriptions of current or expired trials conducted by Boston IVF. The ISIS and FORTT trials were done in affiliation with Harvard Medical School, Dartmouth College and Beth Israel Deaconess Medical Center (BIDMC) and werefunded by the National Institutes of Health (NIH), the primary agency for conducting medical research.
ISIS STUDY: The purpose of this study is to evaluate the link between lifestyle and fertility. This study is currently recruiting women age 20-34 and their male partners who are planning their first pregnancy. Click here for more information on this trial. Additionally, Boston IVF initiates new research projects on a regular basis. If you are interested in enrolling in a study or learning more about our research, please speak with your Boston IVF physician or our Study Coordinator, Kristin B.
ANTI-MULLERIAN HORMONE (AMH) STUDY
The purpose of the study is to evaluate a new lab test for Anti-Mullerian Hormone (AMH). This is a blood test that may give us information about your fertility. Participants will be asked to have an extra tube of blood drawn on one occasion and share information from their medical record about their health histpry. This will include the results of your ultrasound.
Eligible participants are:
• Women seeking fertility treatment/assessment at Boston IVF
• Between the ages of 21-44
Qualified participants will be compensated $50 for their involvement in this study.
If you are interested in learning more about this study and whether you may be eligible to participate, please contact Study Coordinator Kristin Rooney at 781.434.6470.